As an alternative to FDA-approved brand name products, a provider may prescribe a compounded drug where medically appropriate after an online consultation
As a result, your body may struggle to maintain tissues in your heart, muscle, liver, bone, and kidney
More serious but rare risks include pancreatitis, gallbladder disease, and potential thyroid concerns (based on animal studies with GLP-1 receptor agonists)
And while weight loss is often part of the conversation, its rarely the whole story
Indeed, in addition to pancreatic beta cells, semaglutide signals to various other cell types expressing the GLP-1 receptor [45], [46], which could trigger additional physiological responses
This positions retatrutide results favorably for long-duration preclinical study designs